Cytokines in primary biliary cirrhosis

Seminars in Liver Disease

Volumn 17, Issue 2, 1997, Pages 115-123

  Berg, Peter A ^a   Klein, Reinhild ^a   Röcken, Martin ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Cytokines; Primary biliary cirrhosis; T cell subpopulations

Indexed keywords

ALLERGEN; ANTIGEN; AUTOANTIBODY; CD30 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GOLD SALT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MYELIN BASIC PROTEIN; PENICILLAMINE; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ARTICLE; AUTOIMMUNITY; BASOPHIL; DELAYED HYPERSENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNOREACTIVITY; INFLAMMATION; MAST CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0030977867     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1007189     Document Type: Article

References (84)

1. H2 and more. Immunol Today 17:138-46, 1996.
2. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12.227-57, 1994.
3. Röcken M, Racke M, Shevach EM: IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-31, 1996.
4. Mosmann TR, Cherwinski H, Bond MW, et al: Two types of murine helper T-cell clone: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-57, 1986.
5. Brod SA, Benjamin D, Hafler DA: Restricted T cell expression of IL-2/IFN-γ mRNA in human inflammatory disease. J Immunol 147:810-5, 1991.
6. +T-cell clones. J Immunol 1141:849-55, 1988.
7. H2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18:301-8, 1994.
8. Maggi E, Del Prete GF, Macchia D, et al: Profiles of lymphokine activities and helper function for IgE in human T cell clones. Eur J Immunol 18:1045-54, 1988.
9. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-51, 1994.
10. Kamogawa Y, Minasi LE, Carding SE, et al: The relationship of IL-4 and IFN gamma-producing T cells studied by lineage ablation of IL-4 producing cells. Cell 75:985-95, 1993.
11. H2 subsets: paradigms lost? Immunol Today 16:374-379, 1995.
12. Garside P, McI Mowat A: Polarization of Th-cell responses: a phylogenetic consequence of non-specific immune defence? Immunol Today 16:220-3, 1995.
13. Khoury SJ, Hancock WW, Weiner HL: Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176.1355-64, 1992.
14. Merill JE, Kono DH, Clayton J, et al: Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc Natl Acad Sci USA 89:574-8, 1992.
15. Miller SD, Karpus WJ: The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol Today 15:356-61, 1994.
16. Racke MK, Bonomo A, Scott DE, et al: Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-6, 1994.
17. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-8, 1995.
18. Charteris DG, Lightman SL: In vivo lymphokine production in experimental autoimmune uveoretinitis. Immunology 78.387-92, 1993.
19. Higuchi M, Diamantstein T, Osawa H, Caspi RR: Combined anti-interleukin-2 receptor and low-dose cyclosporine therapy in experimental autoimmune uveoretinitis. J Autoimmun 4: 113-24, 1991.
20. Saoudi A, Castedo M, Nochy D, et al: Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polyclonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients. Eur J Immunol 25:1972-9, 1995.
21. Shehadeh NN, La Rosa F, Lafferty KJ: Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 6:291-300, 1993.
22. Bergman B, Haskins K: Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes 43:197-203, 1994.
23. Hahn HJ, Lucke S, Kloting I, et al: Curing BB rats of freshly manifested diabetes by short term treatment with a combination of a monoclonal anti-interleukin-2 receptor antibody and a subtherapeutical dose of cyclosporin A. Eur J Immunol 18: 2037-42, 1987.
24. Baran D, Lantz O, Dosquet P, et al: Interleukin-2 production in Brown-Norway rats with HgC12-induced autoimmune disease: paradoxical in vivo versus in vitro findings. Clin Exp Immunol 73:401-5, 1988.
25. H2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals. Eur Cytokine Netw 2.147-52, 1991.
26. H2 cells modified with DNA methylation inhibitors in vitro cause autoimmune in vivo. J Immunol 154:3025-35, 1995.
27. H2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically induced autoimmunity. Immunol Today 12:223-7, 1991.
28. H2: doubt no more. Immunol Today 12:256-7, 1991.
29. Wierenga EA, Snoek M, Jansen HM, et al: Human atopen-specific types 1 and 2 T helper cell clones. J Immunol 147:2942-9, 1991.
30. + T cells. Immunol Today 12:392-5, 1991.
31. Del Prete GF, De Carli M, Mastromauro C, et al: Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 88:346-50, 1991.
32. Foulis AK, McGill M, Farquharson MA: Insulitis in type I (insulin-dependent) diabetes mellitus in man: Macrophages, lymphocytes, and interferon-γ containing cells. J Pathol 165:97-103, 1991.
33. Selmaj K, Raine CS, Cannella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-54, 1991
34. Benvenuto R, Paroli M, Buttinelli C, et al: Tumor necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis. Clin Exp Immunol 84: 97-102, 1991.
35. H1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J Clin Endocrinol Metab 77:1120-4, 1993.
36. Matthews N, Emery P, Pilling D, et al: Subpopulations of primed T helper cells in rheumatoid arthritis. Arthritis Rheum 36:603-7, 1993.
37. H0) cytokine patterns. Scand J Immunol 38:75-82, 1993.
38. Gray D: Immunological memory. Annu Rev Immunol 11: 49-77, 1993.
39. Mackay CR: T-cell memory: the connection between function, phenotype and migration pathways. Immunol Today 12:189-92, 1991.
40. Clement LT: Isoforms of the CD45 common leukocyte antigen family: markers for human T-cell differentiation. Clin Immunol 12.1-13, 1992.
41. Beverley PC: Functional analysis of human T cell subsets defined by CD45 isoform expression. Semin Immunol 4:35-41, 1992.
42. H2 cell clones. Eur J Immunol 21:17-22, 1991.
43. + T cells defined by their expression of different isoforms of the leukocyte-common antigen, CD45. Biochem Soc Trans 20:188-90, 1992.
44. Thomas R, McIlraith M, Davis LS, Lipsky PE: Rheumatoid synovium is enriched in CD45RBdim mature memory T-cells that are potent helpers for B-cell differentiation. Arthritis Rheum 35:1455-65, 1992.
45. Morrissey PJ, Charrier K, Braddy S, et al: CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice: disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med 178:237-44, 1993.
46. H2-type cytokines. FASEB J 9:81-6, 1995.
47. H2-type cytokines: evidence for large numbers of CD3+CD30+ T cell clones in human immunodeficiency virus (HIV) infection. J Exp Med 180:2407-11, 1994.
48. H2 cytokines and HIV infection: a complex and fascinating link. Immunol Today 16:76-80, 1995.
49. Alzona M, Jack HM, Fischer RI, Ellis TM: CD30 defines a subset of activated human T-cells that produce γIFN and IL-5 and exhibit enhanced B-cell helper activity. J Immunol 153:2861-7, 1994.
50. H2 cytokine responses: the cytokine production profile of T cells is dedicated by the primary in vitro stimulus. Eur J Immunol 23:1-5, 1993.
51. H2-type T cells. J Immunol 156:1387-91, 1996.
52. Ellis TM, Simms PE, Slivnick DJ, et al: CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T-cells. J Immunol 151:2380-9, 1993.
53. Röcken M, Saurat K-H, Hauser C: A common precursor for CD4+ T cells producing IL-2 or IL-4. J Immunol 148:1031-6, 1992.
54. Mosmann TR, Schumacher JH, Street NF, et al: Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol Rev 123:209-29, 1991.
55. Steinman L: The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease. Adv Immunol 49:357-79, 1991.
56. Vajdy M, Kosco-Vilbois MH, Kopf M, et al: Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med 181:41-53, 1995.
57. Assenmacher M, Schmitz J, Radbruch A: Flow cytometric determination of cytokines in activated murine Th lymphocytes: expression of IL-10 in IFN-γ and in IL-4 expressing cells. Eur J Immunol 24:1097-101, 1994.
58. Vollmer S, Menssen A, Trommler P, et al: T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24: 2377-82, 1994.
59. Yoshimoto T, Paul WE: CD4 pos, NK1.1 pos T cells promptly produce interleukin 4 in response to in vivo challenge. J Exp Med 179:1285-95, 1994.
60. Llorente L, Richard-Patin Y, Flor R, et al: In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome and systemic lupus erythematosus: a potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum 37:1647-55, 1994.
61. Llorente L, Zou W, Levy Y, et al: Role of interleukin-10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839-44, 1995.
62. Salgame P, Abrams JS, Clayberger C, et al: Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279-82, 1991.
63. Yu M, Fredrikson S, Link J, Link H: High numbers of autoantigen-reactive mononuclear cells expressing interferon-gamma (IFN-γ), IL-4 and transforming growth factor-beta (TGFβ) are present in cord blood. Clin Exp Immunol 101:190-6, 1995.
64. Klein R, Leuschner M, Leuschner U, Berg PA: Cytokines in primary biliary cirrhosis and primary sclerosing cholangitis. In: Berg PA, Leuschner U, (eds): Bile Acids and Immunology. Dordrecht/Boston/London: Kluwer Academic Publishers, 1996, 195-215.
65. Martinez OM, Villanueva JC, Gershwin ME, Krams SM: Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 21:113-9, 1995.
66. Löhr HF, Schlaak JF, Gerken G, et al: Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 14:161-6, 1994.
67. Leon MP, Spickett G, Jones DEJ, Bassendine MF: CD4+ T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 99:233-9, 1995.
68. Miller LC, Kaplan MM: Serum interleukin-2 and tumor necrosis factor-α in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 87:465-70, 1992.
69. Broomé U, Eriksson LS, Sundin U, Sundqvist K-G: Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis patients. Scand J Gastroenterol 27:124-8, 1992.
70. Jones A, Selby PJ, Viner C, et al: Tumor necrosis factor, cholestatic jaundice, and chronic liver disease. Gut 31:938-9, 1990.
71. Miller LC, Sharma A, McKusick AF, et al: Synthesis of interleukin-1 in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression. Hepatology 22:518-24, 1995.
72. Tilg H, Wilmer A, Vogel W, et al: Serum levels of cytokines in chronic liver diseases. Gastroenterology 103:264-74, 1992.
73. Müller C, Zielinski CC: Interleukin-6 production by peripheral blood monocytes in patients with chronic liver disease and acute viral hepatitis. J Hepatol 15:372-7, 1992.
74. Spengler U, Möller A, Jung MC, et al: T-lymphocytes from patients with primary biliary cirrhosis produce reduced amounts of lympotoxin. tumor necrosis factor and interferon gamma upon mitogen stimulation. J Hepatol 15:129-35, 1992.
75. Klein R, Klöppel G, Garbe W, et al: Antimitochondrial antibody profiles determined at early stages of primary biliary cirrhosis differentiate between a benign and a progressive course of the disease: a retrospective analysis of 76 patients over 6-18 years. J Hepatol 12.21-7, 1991.
76. Kaufman DL, Clare-Salzler M, Tian J, et al: Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366:69-72, 1993.
77. Tisch R, Yang XD, Singer SM, et al: Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366:72-5, 1993.
78. Van de Water J, Ansari A, Prindiville T, et al: Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis. J Exp Med 181:723-33, 1995.
79. Jones DEJ, Palmer JM, James OFW, et al: T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis Hepatology 21:995-1002, 1995.
80. Berg PA, Klein R: Mitochondrial antigen/antibody systems in primary biliary cirrhosis. revisited. Liver 15:281-92, 1995.
81. Mackay IR, Gershwin ME: Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis. Immunol Today 10:315-8, 1989.
82. Nakanuma Y, Tsuneyama K, Gershwin ME, Yasoshima M: Pathology and immunopathology of primary biliary cirrhosis with emphasis on bile duct lesions: recent progress. Semin Liver Dis 15:313-28, 1995.
83. Snapper CM, Paul WE: Interferon-γ and B-cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944-7. 1987.
84. Berg PA, Klein R: Autoantibody patterns in primary biliary cirrhosis. In: Krawitt EL, Wiesner RH (eds): Autoimmune Liver Diseases. New York: Raven Press, 1991, pp 123-42.